of pyridine. 6 was suspended in diethyl ether and methanol
to give a saturated solution, which was deprotected with HCl
generated in situ from acetyl chloride.22 Regular monitoring of
the reaction allowed isolation of 5 in 55% yield over 2 steps.
Compound 5 was phosphorylated regioselectively affording 9 in
88%. Subsequent deprotection of the silyl group under acidic
conditions proceeded smoothly in 94% yield. Hydrogenation of
3 allowed near quantitative phosphate deprotection to furnish 2
in a 45% yield over five steps. Thus, we obtained phosphorylation
yields similar to those discovered through flow chemistry using
a convenient and scalable batch process that offers a significant
improvement in yield over the conventional reaction (Scheme 1a).
In conclusion, we have used flow chemistry to study the
desymmetrization of trehalose. This has produced kinetic data
that has given vital insights into the mechanism of these seem-
ingly simple reactions. This data can explain previous literature
reports of low yielding monofunctionalizations on deprotected
trehalose. Strategies to improve dissolution of trehalose, such as
dilute reaction mixtures, or protection of secondary hydroxyls
are possible workarounds. Alternatively, a reverse modification
route can exploit phase effects to give greater than statistical
monofunctionalization yields. The facile, scalable synthesis of
5 can be readily incorporated into synthetic routes for other
non-symmetrical trehalose analogues and, together with the
reverse modification approach in general, could lead to significant
improvements in yield. The potential also exists for extension
of the principle, for example, to pseudosymmetric disaccharide
polyols allowing access to modifications at one primary hydroxyl
in the presence of another.
Fig. 3 Yield of 5 versus time for different solvents.
solvent to exploit solubility differences of trehalose adducts, yields
of monofunctionalization were improved through manipulation
of k2.‡
Such “phase control” of reactions has been utilized in enzymatic
synthesis to shift reaction equilibria towards the product by judi-
cious choice of solvent.19 Understanding the physics of attrition
grinding deracemizations (another “phase controlled” process)20
has allowed for the enantiopure synthesis of the non-steroidal anti-
inflammatory drug Naproxen.21 Analogously, by understanding
the kinetics of trehalose desymmetrizations, we have optimized
conditions for the synthesis of 2, an important natural signalling
molecule.
To avoid the potential for precipitation under such reduced
solubility conditions (with subsequent blockage of the microreac-
tor) and to create a more generally applicable route for increased
scale, we used the kinetic data and conditions discovered using
the flow methods to develop a batch method. In this way,
flow discovery allowed batch optimization. Thus under these
newly discovered conditions, silylation of 1 smoothly gave 6
(Scheme 3). The crude product was used directly after removal
Acknowledgements
We are grateful to the International AIDS Vaccine Initiative for
financial support. BGD is a Royal Society Wolfson Research Merit
Award recipient and supported by an EPSRC LSI Platform grant.
Notes and references
‡ The rate constants k1 and k2 refer to the apparent rate constants. Due to
the poor solubility of the trehalose analogues, the actual concentration of
these compounds in solution cannot be determined. Thus, while the actual
rate constants cannot be measured, it is mathematically convenient in the
context of these discussions to express the reductions in rate as apparent
rate constants.
1 M. J. Paul, L. F. Primavesi, D. Jhurreea and Y. Zhang, Annu. Rev. Plant
Biol., 2008, 59, 417.
2 J. H. Crowe, J. F. Carpenter and L. M. Crowe, Annu. Rev. Physiol.,
1998, 60, 73; F. Albertorio, V. A. Chapa, X. Chen, A. J. Diaz and P. S.
Cremer, J. Am. Chem. Soc., 2007, 129, 10567.
´
´
3 J. L. Chiara, I. S. de Gracia, A. Garc´ıa, A. Bastida, S. Bobo and M. D.
Mart´ın-Ortega, ChemBioChem, 2005, 6, 186; Y. Hui and C. T. Chang,
Org. Lett., 2002, 4, 2245.
4 P. J. Brennan and H. Nikaido, Annu. Rev. Biochem., 1995, 64, 29; D. E.
Minnikin, L. Kremer, L. G. Dover and G. S. Besra, Chem. Biol., 2002,
9, 545.
5 J. D. Rose, J. A. Maddry, R. N. Comber, W. J. Suling, L. N. Wilson and
R. C. Reynolds, Carbohydr. Res., 2002, 337, 105; J. Wang, B. Elchert,
Y. Hui, J. Y. Takemoto, M. Bensaci, J. Wennergren, H. Chang, R. Rai
and C. T. Chang, Bioorg. Med. Chem., 2004, 12, 6397.
6 M. Paul, Curr. Opin. Plant Biol., 2007, 10, 303; I. Pe´rez-Victoria, S.
Kemper, M. K. Patel, J. M. Edwards, J. C. Errey, L. F. Primavesi, M. J.
Paul, T. D. W. Claridge and B. G. Davis, Chem. Commun., 2009, 5862.
7 M. A. Rodr´ıguez, O. Boutureira, M. I. Matheu, Y. D´ıaz, S. Castillo´n
and P. H. Seeberger, J. Org. Chem., 2007, 72, 8998.
Scheme 3 Conditions: (i) tert-butyldiphenylchlorosilane, py, 14 h; (ii)
AcCl, MeOH–Et2O 1 : 3 18 h; (iii) diphenyl chlorophosphate, py, 15 h; (iv)
AcCl, MeOH, 18 h; (v) H2, PtO2, AcOH, EtOH, 14 h.
4234 | Org. Biomol. Chem., 2010, 8, 4232–4235
This journal is
The Royal Society of Chemistry 2010
©